-+ 0.00%
-+ 0.00%
-+ 0.00%

Olema Reports Selective KAT6A Degraders Potently Inhibit Proliferation In Diverse ER+/HER2- Breast Cancer Models, Active In ESR1-Mutant And Wild-Type, Well-Tolerated

Benzinga·11/18/2026 07:48:02
  • Orally bioavailable KAT6A degraders demonstrated potent antiproliferative activity in diverse in vivo models of ER+/HER2- breast cancer
  • KAT6A degradation was active in both ESR1-mutant and wild-type cell models
  • Degraders were well-tolerated in all groups